Clinical Study
Investigating the Efficacy of an Individualized Alpha/Delta Neurofeedback Protocol in the Treatment of Chronic Tinnitus
Table 5
Results of the repeated-measure mixed model ANOVA for control comparisons.
| | | df | |
| Standard bands | | | | EEG-NT | | | | Delta | 6.60 | 2 | 0.037 | Theta | 1.20 | 2 | 0.549 | L-Alpha | 1.24 | 2 | 0.538 | U-Alpha | 1.05 | 2 | 0.591 | Alpha | 1.07 | 2 | 0.587 | Beta1 | 0.17 | 2 | 0.917 | Beta2 | 2.41 | 2 | 0.300 | Beta3 | 1.82 | 2 | 0.402 | Gamma | 1.00 | 2 | 0.607 | EEG-WT | | | | Delta | 8.70 | 2 | 0.013 | Theta | 1.49 | 2 | 0.474 | L-Alpha | 0.25 | 2 | 0.881 | U-Alpha | 0.17 | 2 | 0.916 | Alpha | 0.70 | 2 | 0.706 | Beta1 | 0.36 | 2 | 0.836 | Beta2 | 0.15 | 2 | 0.925 | Beta3 | 3.11 | 2 | 0.211 | Gamma | 4.25 | 2 | 0.119 |
| Ratio over all electrodes | | | | EEG-NT | 9.67 | 2 | 0.008 | EEG-WT | 9.60 | 2 | 0.008 |
| Control for age group | | | | THI | 4.57 | 4 | 0.335 | TQ | 8.24 | 4 | 0.083 | Loudness | 1.39 | 4 | 0.846 | Ratio EEG-NT | 7.66 | 3 | 0.054 | Ratio EEG-WT | 1.52 | 3 | 0.677 |
|
|
|